NCT00466895
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Disease, +19 more
- Locations
-
- Ohio State University Medical Center Columbus, Ohio, United States
Clinical trial condition
Leukemia, Lymphoid
Explore clinical trials studying Leukemia, Lymphoid. Study availability and eligibility vary by location and protocol.
3,018 public trials
549 recruiting studies
Leukemia, Lymphoid trial results
NCT00406757
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- GSK Investigational Site Aichi, Japan
- GSK Investigational Site Tokyo, Japan
- GSK Investigational Site Tokyo, Japan
NCT01110031
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
- Locations
-
- GSK Investigational Site La Jolla, California, United States
- GSK Investigational Site Randwick, New South Wales, Australia
- GSK Investigational Site Auckland, New Zealand
- GSK Investigational Site Christchurch, New Zealand
NCT00964821
- Conditions
- Anemia, Anemia, Aplastic, Blast Crisis, +73 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- City of Hope Medical Group Pasadena, California, United States
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +16 more
- Locations
-
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
NCT00945815
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
- University of California Davis Cancer Center Sacramento, California, United States
NCT00425802
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +21 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
Completed
CD19-targeting 3rd Generation CAR T Cells for Refractory B Cell Malignancy - a Phase I/IIa Trial.
NCT02132624
- Conditions
- B Cell Leukemia, B Cell Lymphoma, Hematologic Diseases, +13 more
- Locations
-
- Uppsala University Hospital, Dept of Oncology Uppsala, Sweden
NCT00003659
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
NCT01786135
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +22 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- City of Hope National Medical Center Duarte, California, United States
- Stanford Cancer Center Stanford, California, United States
- H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States